Zai Lab ZLAB
NASDAQ ZLAB
$26.28 -0.72 (-2.67%)
As of: Sep 4, 2026 · 3:18 PM EDT

Zai Lab (ZLAB) Free Cash Flow (2018 - 2026)

Zai Lab (ZLAB) posted Free Cash Flow of -$13.1 million for Q1 2026, up 50.91% sequentially from -$26.7 million in Q4 2025, and up 79.27% YoY from -$7.3 million in Q1 2025.

Analysis

Zai Lab (ZLAB) Free Cash Flow (2018 - 2026) Analysis & Trends

Zai Lab has reported Free Cash Flow for 9 years, with the latest figure at -$13.1 million in Q1 2026.

  • Quarterly Free Cash Flow rose 79.27% year-over-year to -$13.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$108.8 million (up 43.55% YoY) and the FY2025 annual result came in at -$158.9 million, up 27.95% from the prior year.
  • Free Cash Flow rose to -$13.1 million in Q1 2026 per ZLAB's latest filing, from -$26.7 million in the prior quarter.
  • Over five years, Free Cash Flow peaked at -$13.1 million in Q1 2026 and troughed at -$133.0 million in Q3 2022.
  • A 5-year average of -$58.2 million and a median of -$57.0 million in 2023 frame the typical range for Free Cash Flow.
  • The sharpest annual moves came in 2023 and 2024: Free Cash Flow jumped 86.69% in 2023, then slumped 285.55% in 2024.
  • Over 5 years, Free Cash Flow stood at -$113.7 million in 2022, then surged by 86.69% to -$15.1 million in 2023, then plunged by 285.55% to -$58.4 million in 2024, then soared by 54.26% to -$26.7 million in 2025, then soared by 50.91% to -$13.1 million in 2026.
  • According to Business Quant data, Free Cash Flow over the past three periods registered -$13.1 million, -$26.7 million, and -$35.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Vertex Pharmaceuticals 138.43 Bn 130.58 Bn 2.84 Bn 1.01 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 572.80 Mn
3 Argenx Se 63.34 Bn 58.15 Bn 1.37 Bn -
4 Moderna 57.98 Bn 52.85 Bn 52.00 Mn -563.00 Mn
5 Revolution Medicines 43.98 Bn 43.98 Bn - -389.61 Mn
6 BeOne Medicines 39.92 Bn 34.82 Bn 1.53 Bn 437.80 Mn
7 Alnylam Pharmaceuticals 35.42 Bn 32.11 Bn 992.69 Mn 292.04 Mn
8 Royalty Pharma 28.42 Bn 27.58 Bn - 477.44 Mn
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn -95.09 Mn
10 Zai Lab 2.94 Bn 2.23 Bn 58.15 Mn -64.72 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -64.72 Mn
Mar 31, 2026 -13.11 Mn
Dec 31, 2025 -26.70 Mn
Sep 30, 2025 -35.05 Mn
Jun 30, 2025 -33.91 Mn
Mar 31, 2025 -63.23 Mn
Dec 31, 2024 -58.37 Mn
Sep 30, 2024 -28.16 Mn
Jun 30, 2024 -42.91 Mn
Mar 31, 2024 -91.08 Mn
Dec 31, 2023 -15.14 Mn
Sep 30, 2023 -57.03 Mn
Jun 30, 2023 -60.42 Mn
Mar 31, 2023 -72.80 Mn
Dec 31, 2022 -113.71 Mn
Sep 30, 2022 -133.01 Mn
Jun 30, 2022 -48.65 Mn
Mar 31, 2022 -96.87 Mn
Dec 31, 2021 -159.37 Mn
Sep 30, 2021 -167.16 Mn